Workflow Services Supports Walgreens National Colorectal Cancer Initiative to Close Screening Gaps; Leverages Cologuard(R) Tests to Expand Reach

{
  "signal_id": "c470a77c-8ba7-4d3a-b462-8d600eaacaf3",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-03-13T00:00:00+00:00",
  "company": {
    "name": "Walgreens",
    "domain": "walgreens.com"
  },
  "data": {
    "url": "https://pr.enewspf.com/article/Workflow-Services-Supports-Walgreens-National-Colorectal-Cancer-Initiative-to-Close-Screening-Gaps-Leverages-Cologuardr-Tests-to-Expand-Reach?storyId=69b395f93971457808b098eb",
    "title": "Workflow Services Supports Walgreens National Colorectal Cancer Initiative to Close Screening Gaps; Leverages Cologuard(R) Tests to Expand Reach",
    "excerpt": "Workflow Services supports Walgreens national Colorectal Cancer initiative to close screening gaps; leverages Cologuard(R) tests to expand reach.\n\nPR Newswire\n\nToday at 9:39pm PDT\n\nPR Newswire\n\nMADISON, Wis., March 13, 2026\n\nMADISON, Wis., March 13, 2026 /PRNewswire/ - Beginning today, Walgreens customers can access tools and resources to better understand their colorectal cancer screening options - including a streamlined pathway that enables eligible, average-risk patients to request screening with the Cologuard(R) test. In recognition of Colorectal Cancer Awareness Month and to help remove barriers to screening and support earlier detection of colorectal cancer, when it is most treatable, Walgreens is working to increase awareness of non-invasive screening options by teaming up with Exact Sciences, the maker of Cologuard, and Workflow Services, a pharmacy clinical workflow platform that integrates screening programs directly into pharmacy operations.\n\nColorectal cancer is often called a \"silent\" disease because it frequently develops without symptoms. It is expected to claim more than 55,000 lives in the U.S. this year alone and has become the #1 cause of cancer death in adults under 50.[1,2]\n\nColorectal cancer is also highly preventable.[3] Screening for colorectal cancer can help find pre-cancerous growths (polyps) so they can be removed before they turn into cancer. When...",
    "summary": "Walgreens partners with Exact Sciences Corporation.",
    "category": "partners_with",
    "found_at": "2026-03-13T00:00:00Z",
    "planning": false,
    "image_url": "https://www.enewspf.com/wp-content/uploads/2023/01/logo-enewspf.png",
    "confidence": 0.9134,
    "published_at": "2026-03-13T00:00:00Z",
    "article_sentence": "In recognition of Colorectal Cancer Awareness Month and to help remove barriers to screening and support earlier detection of colorectal cancer, when it is most treatable, Walgreens is working to increase awareness of non-invasive screening options by teaming up with Exact Sciences, the maker of Cologuard, and Workflow Services, a pharmacy clinical workflow platform that integrates screening programs directly into pharmacy operations."
  }
}

curl https://signals.autobound.ai/v1/signals/c470a77c-8ba7-4d3a-b462-8d600eaacaf3 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"walgreens.com","limit":20}'